Toronto - Delayed Quote CAD

Cipher Pharmaceuticals Inc. (CPH.TO)

13.20
-0.71
(-5.10%)
At close: 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
39,515
33,363
21,162
20,675
21,943
Cost of Revenue
11,084
9,260
4,069
3,992
3,684
Gross Profit
28,431
24,103
17,093
16,683
18,259
Operating Expense
21,164
16,255
6,791
5,633
5,200
Operating Income
7,267
7,848
10,302
11,050
13,059
Net Non Operating Interest Income Expense
-695
330
1,870
464
-80
Other Income Expense
-4,698
-5,223
509
-35
-1,920
Pretax Income
1,874
2,955
12,681
11,479
11,059
Tax Provision
-7,372
-8,590
-7,702
-15,157
3,301
Net Income Common Stockholders
9,246
11,545
20,383
26,636
7,758
Diluted NI Available to Com Stockholders
9,246
11,545
20,383
26,636
7,758
Basic EPS
0.36
0.47
0.82
1.05
0.29
Diluted EPS
0.36
0.46
0.80
1.03
0.29
Basic Average Shares
25,125.41
24,721
24,857.32
25,376.29
26,597.84
Diluted Average Shares
25,673.54
25,221.89
25,478.75
25,799.16
26,830.02
Total Expenses
32,248
25,515
10,860
9,625
8,884
Net Income from Continuing & Discontinued Operation
9,246
11,545
20,383
26,636
7,758
Normalized Income
13,239.30
15,984.55
20,077.60
26,661.83
9,104.90
Interest Income
--
330
1,870
464
12
Interest Expense
--
--
--
--
92
Net Interest Income
-695
330
1,870
464
-80
EBIT
7,267
7,848
10,302
11,050
13,059
EBITDA
12,817
11,865
11,529
12,039
13,760
Reconciled Cost of Revenue
11,084
9,260
4,069
3,992
3,684
Reconciled Depreciation
5,550
4,017
1,227
989
701
Net Income from Continuing Operation Net Minority Interest
9,246
11,545
20,383
26,636
7,758
Total Unusual Items Excluding Goodwill
-4,698
-5,223
509
-35
-1,920
Total Unusual Items
-4,698
-5,223
509
-35
-1,920
Normalized EBITDA
17,515
17,088
11,020
12,074
15,680
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-704.70
-783.45
203.60
-9.17
-573.10
12/31/2021 - 5/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RX.V BioSyent Inc.
10.88
+0.28%
 
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.4400
+2.33%
 
MOB.ST Moberg Pharma AB (publ)
7.35
-0.68%
 
SBBC.V Simply Better Brands Corp.
0.9700
-1.02%
 
MDP.TO Medexus Pharmaceuticals Inc.
2.7300
-6.51%
 
HLS.TO HLS Therapeutics Inc.
4.5000
-3.23%
 
GUD.TO Knight Therapeutics Inc.
5.86
+2.63%
 
CRON.TO Cronos Group Inc.
2.8600
+3.62%
 
OGI.TO Organigram Global Inc.
1.8000
+9.76%
 
BHC.TO Bausch Health Companies Inc.
6.69
+4.86%